uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Destara
Withdrawn
Human
Details
EMA number
EMEA/H/C/000103
ATC code
M05BA06
Authorisation
25 June 1996
Revision
-
EMA page
Therapeutic indication
Treatment of tumour-induced hypercalcaemia with or without metastases.
MeSH:
Hypercalcemia;Cancer
Group:
Drugs for treatment of bone diseases
Active substances
ibandronic acid
Marketing Authorisation Holder
Roche Registration Ltd.
MAH
Timeline
Filter by authority:
EMA
Destara authorised
25 Jun 1996
authorised
regulatory
Destara | uMedical